38 CFR § 17.1220 - Provision of emergent suicide care.

---
identifier: "/us/cfr/t38/s17.1220"
source: "ecfr"
legal_status: "authoritative_unofficial"
title: "38 CFR § 17.1220 - Provision of emergent suicide care."
title_number: 38
title_name: "Pensions, Bonuses, and Veterans' Relief"
section_number: "17.1220"
section_name: "Provision of emergent suicide care."
chapter_name: "DEPARTMENT OF VETERANS AFFAIRS"
part_number: "17"
part_name: "MEDICAL"
positive_law: false
currency: "2026-04-05"
last_updated: "2026-04-05"
format_version: "1.1.0"
generator: "[email protected]"
authority: "38 U.S.C. 501, and as noted in specific sections."
cfr_part: "17"
---


# 17.1220 Provision of emergent suicide care.

(a) Emergent suicide care will be provided to individuals eligible under § 17.1210 only if it is determined by a health care provider to be clinically necessary and in accord with generally accepted standards of medical practice.

(b) Prescription drugs, biologicals, and medical devices that may be provided during a period of emergent suicide care under § 17.1215 must be approved by the Food and Drug Administration, unless the treating VA facility or non-VA facility is conducting formal clinical trials under an Investigational Device Exemption or an Investigational New Drug application, or the drugs, biologicals, or medical devices are prescribed under a compassionate use exemption.